Noncoding RNAs: the shot callers in tumor immune escape

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Immunotherapy shows promise against cancer but faces limitations like low response rates and side effects.
• Tumor immune escape is a critical factor contributing to immunotherapy failure.
• Noncoding RNAs (ncRNAs) are emerging as crucial regulators in both cancer development and immune responses.

Purpose of the Study:

• To comprehensively review the current understanding of ncRNAs involved in tumor immune escape (TIE).
• To elucidate the roles of ncRNAs in tumor growth and survival mechanisms.
• To provide insights for improving immunotherapy efficacy by targeting ncRNAs in TIE.

Main Methods:

• Literature review and synthesis of existing research on ncRNAs and tumor immune escape.
• Analysis of the regulatory functions of ncRNAs in the context of the tumor microenvironment and immune evasion.
• Identification of potential therapeutic strategies targeting ncRNAs for enhanced cancer immunotherapy.

Main Results:

• ncRNAs play significant roles in various aspects of tumor immune escape.
• Specific ncRNAs are implicated in modulating immune cell function and tumor progression.
• Understanding ncRNA involvement in TIE offers novel therapeutic avenues.

Conclusions:

• ncRNAs are critical mediators of tumor immune escape, impacting immunotherapy outcomes.
• Targeting ncRNAs involved in TIE presents a promising strategy to overcome treatment resistance.
• Further research into ncRNA-TIE interactions can lead to improved cancer immunotherapy regimens.